HFA Premium Access

Association of the novel cardiovascular biomarkers ST2, GDF-15, suPAR and H-FABP with clinical parameters in heart failure patients

Presentation

About the speaker

Doctor Peter Jirak

Salzburg university hospital, Salzburg (Austria)
0 follower

13 more presentations in this session

NT-proBNP correlates with LAVi and LVMMi in patients with beta-thalassemia major

Speaker: Doctor M. Dimova-Mileva (Varna, BG)

Thumbnail

Assessment nt-probnp in patients with chronic systolic heart failure depending of the quality of life

Speaker: Associate Professor V. Maslovskyi (Vinnytsia, UA)

Thumbnail

Effect of sacubitril/valsartan therapy on risk stratification biomarkers in a real-world heart failure population

Speaker: Doctor M. Barrett (Dublin, IE)

Thumbnail

B-type natriuretic peptide and stage B heart failure in the prediction of cardiovascular events and death in hypertension.

Speaker: Doctor C. Watson (Belfast, GB)

Thumbnail

Features of correlation between NT-proBNP and circadian blood pressure profile in patients with arterial hypertension and chronic heart failure with preserved ejection fraction of the left ventricle

Thumbnail

Access the full session

Poster Session 4 - Biomarkers

Speakers: Doctor P. Jirak, Doctor M. Dimova-Mileva, Associate Professor V. Maslovskyi, Doctor M. Barrett, Doctor C. Watson
Thumbnail

About the event

Image

Heart Failure 2017 - 4th World Congress on Acute Heart Failure

29 April - 2 May 2017

Sessions Presentations

This platform is supported by

logo Novo Nordisk